apomorphine has been researched along with Autoimmune Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forsham, PH; Karam, JH; Lorenzi, M; McIlroy, MB | 1 |
| Caffarri, G; Capretti, L; Chiodera, P; Coiro, V; Colla, R; Vescovi, PP; Volpi, R | 1 |
| Bohannon, NV; Forsham, PH; Gerich, JE; Karam, JH; Lorenzi, M; Tsalikian, E | 1 |
1 trial(s) available for apomorphine and Autoimmune Diabetes
| Article | Year |
|---|---|
Dopaminergic and cholinergic control of arginine-vasopressin secretion in type I diabetic men.
Topics: Acetylcholine; Adult; Apomorphine; Arginine Vasopressin; Blood Pressure; Diabetes Mellitus, Type 1; Dopamine; Humans; Male; Physostigmine | 1995 |
2 other study(ies) available for apomorphine and Autoimmune Diabetes
| Article | Year |
|---|---|
Increased growth hormone response to dopamine infusion in insulin-dependent diabetic subjects: indication of possible blood-brain barrier abnormality.
Topics: Adult; Apomorphine; Blood-Brain Barrier; Capillary Permeability; Diabetes Mellitus, Type 1; Dopamine; Female; Glucagon; Growth Hormone; Humans; Infusions, Parenteral; Insulin; Physical Exertion | 1980 |
Differential effects of L-dopa and apomorphine on glucagon secretion in man: evidence against central dopaminergic stimulation of glucagon.
Topics: Adult; Apomorphine; Blood Glucose; Diabetes Mellitus, Type 1; Female; Glucagon; Growth Hormone; Humans; Insulin; Levodopa; Male; Prolactin; Receptors, Dopamine | 1977 |